- The stock price of Quanterix Corp (NASDAQ: QTRX) increased by over 30% pre-market. This is why it happened.
The stock price of Quanterix Corp (NASDAQ: QTRX) – a company digitizing biomarker analysis with the goal of advancing the science of precision health – increased by over 30% pre-market. Investors are responding positively to Quanterix announcing a webinar hosted by Kevin Hrusovsky, Quanterix Chairman and Chief Executive Officer, with leading pathologist Dr. John Roback, M.D., Ph.D., Professor of Pathology and Laboratory Medicine, Executive Vice-Chair for Clinical Operations, and Medical Director for Emory Medical Laboratories, to discuss Emory’s implementation of a broad SARS-CoV-2 screening program for students, faculty and staff.
Given the continued spread of SARS-CoV-2 – especially the highly contagious Delta variant of the virus – this webinar will help demonstrate how Simoa-enabled, ultra-sensitive detection of the viral antigen in non-invasively collected samples works, and offer an opportunity for the community to learn from the experiences of Dr. Roback and colleagues.
This webinar will take place on Thursday, Sept. 16, 2021 at 9 a.m., EDT. The discussion will be kicked off by Mr. Hrusovsky, who will provide insights into how Dr. Roback’s work – coupled with advances in COVID/neurological biomarkers – are showing promise to advance the field of preventative medicine and precision health. A Q&A discussion will follow the presentation.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.